ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in August 2024. Updated August 31.
A roundup of FDA’s actions in August 2024.
FDA Output, August 2024
×
